167 related articles for article (PubMed ID: 3376838)
1. Concentration response relationships of amiodarone and desethylamiodarone.
Connolly SJ; Gupta RN; Hoffert D; Roberts RS
Am Heart J; 1988 Jun; 115(6):1208-13. PubMed ID: 3376838
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
Somani P; Simon VA; McManus K
Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
[TBL] [Abstract][Full Text] [Related]
3. The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.
Nattel S; Davies M; Quantz M
Circulation; 1988 Jan; 77(1):200-8. PubMed ID: 2446801
[TBL] [Abstract][Full Text] [Related]
4. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
[TBL] [Abstract][Full Text] [Related]
5. Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.
Greenberg ML; Lerman BB; Shipe JR; Kaiser DL; DiMarco JP
J Am Coll Cardiol; 1987 May; 9(5):1148-55. PubMed ID: 3571754
[TBL] [Abstract][Full Text] [Related]
6. [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels].
Nitsch J; Lüderitz B
Dtsch Med Wochenschr; 1984 Mar; 109(13):492-5. PubMed ID: 6423357
[TBL] [Abstract][Full Text] [Related]
7. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
Escoubet B; Coumel P; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Menasche P; Cheymol G; Piwnica A; Lagier G
Am J Cardiol; 1985 Mar; 55(6):696-702. PubMed ID: 3976511
[TBL] [Abstract][Full Text] [Related]
8. Individual variability of amiodarone distribution in plasma and erythrocytes: implications for therapeutic monitoring.
Maling TJ; Siebers RW; Burgess CD; Taylor C; Purdie G
Ther Drug Monit; 1989; 11(2):121-6. PubMed ID: 2718218
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites.
Stäubli M; Troendle A; Schmid B; Balmer P; Kohler B; Studer H; Bircher J
Eur J Clin Pharmacol; 1985; 29(4):417-23. PubMed ID: 4092724
[TBL] [Abstract][Full Text] [Related]
10. Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.
Baerman JM; Annesley T; DiCarlo LA; Foley MK; Nicklas JM; Crevey BJ; Morady F
Am Heart J; 1986 Apr; 111(4):644-8. PubMed ID: 3953386
[TBL] [Abstract][Full Text] [Related]
11. Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects.
Falik R; Flores BT; Shaw L; Gibson GA; Josephson ME; Marchlinski FE
Am J Med; 1987 Jun; 82(6):1102-8. PubMed ID: 3605129
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone.
Barbieri E; Conti F; Zampieri P; Trevi GP; Zardini P; d'Aranno V; Latini R
J Am Coll Cardiol; 1986 Jul; 8(1):210-3. PubMed ID: 3711518
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic effect of chronic oral amiodarone treatment in dogs with myocardial infarction and reproducibly inducible sustained ventricular arrhythmias.
Abdollah H; Brien JF; Brennan FJ
J Cardiovasc Pharmacol; 1990 May; 15(5):799-807. PubMed ID: 1692941
[TBL] [Abstract][Full Text] [Related]
14. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
Rotmensch HH; Belhassen B; Swanson BN; Shoshani D; Spielman SR; Greenspon AJ; Greenspan AM; Vlasses PH; Horowitz LN
Ann Intern Med; 1984 Oct; 101(4):462-9. PubMed ID: 6476633
[TBL] [Abstract][Full Text] [Related]
15. Myocardial amiodarone and desethylamiodarone concentrations in patients undergoing cardiac transplantation.
Giardina EG; Schneider M; Barr ML
J Am Coll Cardiol; 1990 Oct; 16(4):943-7. PubMed ID: 2212375
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
Plomp TA; Hauer RN; Robles de Medina EO
In Vivo; 1990; 4(2):97-100. PubMed ID: 2129806
[TBL] [Abstract][Full Text] [Related]
17. Plasma and red blood cell concentrations of amiodarone during chronic therapy.
Heger JJ; Solow EB; Prystowsky EN; Zipes DP
Am J Cardiol; 1984 Mar; 53(7):912-7. PubMed ID: 6538381
[TBL] [Abstract][Full Text] [Related]
18. Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes.
Somani P; Bandyopadhyay S; Klaunig JE; Gross SA
Hepatology; 1990 Jan; 11(1):81-92. PubMed ID: 2153095
[TBL] [Abstract][Full Text] [Related]
19. Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure.
Candinas R; Frielingsdorf J; Ha HR; Carrel T; Turina M; Follath F
Eur J Clin Pharmacol; 1998 Jan; 53(5):331-6. PubMed ID: 9516032
[TBL] [Abstract][Full Text] [Related]
20. Effect of blood sample tubes on amiodarone and desethylamiodarone concentrations.
Siebers RW; Chen CT; Ferguson RI; Maling TJ
Ther Drug Monit; 1988; 10(3):349-51. PubMed ID: 3176114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
